Hemostasis in Dentistry
Editat de Richard P. Szumita, Paul M. Szumitaen Limba Engleză Paperback – 24 ian 2019
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 737.73 lei 38-44 zile | |
Springer International Publishing – 24 ian 2019 | 737.73 lei 38-44 zile | |
Hardback (1) | 1026.84 lei 38-44 zile | |
Springer International Publishing – 23 aug 2018 | 1026.84 lei 38-44 zile |
Preț: 737.73 lei
Preț vechi: 776.56 lei
-5% Nou
Puncte Express: 1107
Preț estimativ în valută:
141.19€ • 146.66$ • 117.28£
141.19€ • 146.66$ • 117.28£
Carte tipărită la comandă
Livrare economică 30 ianuarie-05 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783030100339
ISBN-10: 3030100332
Pagini: 204
Ilustrații: VIII, 204 p. 32 illus., 26 illus. in color.
Dimensiuni: 178 x 254 mm
Ediția:Softcover reprint of the original 1st ed. 2018
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland
ISBN-10: 3030100332
Pagini: 204
Ilustrații: VIII, 204 p. 32 illus., 26 illus. in color.
Dimensiuni: 178 x 254 mm
Ediția:Softcover reprint of the original 1st ed. 2018
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland
Cuprins
Fundamentals in Dental Hemostasis: Introduction.- Local Tissues in Hemostasis.- Platelet Review.- Coagulation Enzymes.- Review of Hemostasis (Biochemical and Cell-Based). Pharmacological Considerations: vWD and Perioperative Management in Dentistry.- Hemophilia A and B and Perioperative Management in Dentistry.- Thrombocytopenia and Perioperative Management in Dentistry.- Liver Disease and Perioperative Management in Dentistry.- Less Common Disorders of Hemostasis.- Thromboembolic Risk: Why is Your Patient on an Antithrombotic?.- Antiplatelet Agents.- Anticoagulants. Management of Dental Hemostasis: Perioperative Management of Antiplatelet Medications.- Perioperative Management of Anticoagulants.- Surgical Techniques to Minimize Bleeding and Local Agents for Management of Bleeding/ Topical Hemostatics.- Pharmacological Reversal Agents.- Bleeding Issues Specific to Dentistry.
Notă biografică
Richard P. Szumita, DDS, practices Oral and Maxillofacial Surgery at Northeast Oral and Maxillofacial Surgery, Little Falls, NJ, USA. Dr. Szumita graduated from Case Western Reserve University School of Dentistry in 1988 and has been board certified by the American Board of Oral and Maxillofacial Surgery since 1997. Along with his dedication to private practice, Dr. Szumita devotes much time to the education of dentists and dental specialists. He serves as Associate Chairman of the Department of Dentistry and Associate Director of the Oral and Maxillofacial Surgery Residency Training Program at St. Joseph’s Medical Center, Paterson, New Jersey. He is also a member of the Examination Committee of the American Board of Oral and Maxillofacial Surgery. Dr. Szumita is a Fellow of the American Association of Oral and Maxillofacial Surgeons and the American College of Oral and Maxillofacial Surgeons and a Diplomate of the National Dental Board of Anesthesiology.
Paul M. Szumita, PharmD, FCCM, FASHP, BCCCP, BCPS, is a Clinical Pharmacy Practice Manager and Program Director for the Critical Care Pharmacy Specially Residency Program at Brigham and Women’s Hospital in Boston, Massachusetts, USA. He is dual board certified in pharmacotherapy and critical care pharmacy and is recognized as a Fellow in the American College of Critical Care Medicine and in the American Society of Health-System Pharmacists. Paul has helped develop and is responsible for managing clinical programs aimed at optimizing pharmacotherapy and improving patient outcomes. Paul has an active role in bedside education, clinical research, and guideline development/implementation. Paul is an Adjunct Associate Professor of Pharmacy at three colleges helping to coordinate 15 clinical rotations, training more than 100 students each year. He has more than 50 peer-reviewed publications and serves on several committees focused on improving clinical practice at the local and national level, including the program advisory board for the ASHP Critical Care Pharmacy Specialty Examination Review Course and the SCCM taskforce to revise the 2013 Clinical Practice Guidelines for the Management of Pain, Agitation, and Delirium in Adult Patients in the Intensive Care Unit.
Paul M. Szumita, PharmD, FCCM, FASHP, BCCCP, BCPS, is a Clinical Pharmacy Practice Manager and Program Director for the Critical Care Pharmacy Specially Residency Program at Brigham and Women’s Hospital in Boston, Massachusetts, USA. He is dual board certified in pharmacotherapy and critical care pharmacy and is recognized as a Fellow in the American College of Critical Care Medicine and in the American Society of Health-System Pharmacists. Paul has helped develop and is responsible for managing clinical programs aimed at optimizing pharmacotherapy and improving patient outcomes. Paul has an active role in bedside education, clinical research, and guideline development/implementation. Paul is an Adjunct Associate Professor of Pharmacy at three colleges helping to coordinate 15 clinical rotations, training more than 100 students each year. He has more than 50 peer-reviewed publications and serves on several committees focused on improving clinical practice at the local and national level, including the program advisory board for the ASHP Critical Care Pharmacy Specialty Examination Review Course and the SCCM taskforce to revise the 2013 Clinical Practice Guidelines for the Management of Pain, Agitation, and Delirium in Adult Patients in the Intensive Care Unit.
Textul de pe ultima copertă
This book offers a thorough, clinically oriented review of hemostasis and its impact on the practice of dentistry. Readers will gain a sound understanding of the pathophysiology of hemostasis and the pharmacology of antithrombotic and prothrombotic medications. Perioperative dental management strategies of value in patients with different congenital and acquired disorders of hemostasis are carefully explained, and the role of surgical techniques and local and topical agents in helping to minimize and control bleeding is described. Helpful instruction is also provided on the indications for antithrombotic medications and the management of patients receiving such therapy, including the risks of altering medications. As the number of available oral antithrombotic agents continues to increase, dentists will encounter significantly more patients receiving treatments that affect hemostasis. In presenting comprehensive, up-to-date information on hemostasis, hemostatic disorders, antithrombotic therapy, and safe dental management, this book will serve as a rich source of information and a useful guide for practitioners and students alike.
Caracteristici
Offers a thorough, clinically oriented review of hemostasis and its impact on the practice of dentistry Describes dental management strategies in patients with congenital and acquired disorders of hemostasis Explains how to manage patients receiving antithrombotic medications Supplies essential information on pathophysiology and pharmacology